illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. health care
  6. ›
  7. TCI
Company logo

TCI | Sustainability Performance

https://www.tci-bio.com/

Contract development and manufacturing organization (CDMO) specializing in health supplements and skincare products. Offers research, development, and production services to clients globally.

1980

Taiwan

1,001 - 5,000 employees

Biotechnology

$100M - 500M in revenue

$25M - 100M in profitability

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#2679
Overall
#43
in Taiwan
#43
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Industry Rank

59 out of 244

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Scinopharm Taiwan

Taiwan, Health Care, Pharmaceuticals


Company logo
Sinphar Pharmaceutical

Taiwan, Health Care, Pharmaceuticals


Company logo
Standard Chem & Pharm

Taiwan, Health Care, Pharmaceuticals

Market cap

14.2B $, 2026▲5.4% YoY

Revenue

7.2B $, 2024▲10.7% YoY

R&D intensity

8.45% 2024

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
Powered by illuminem

Market cap

14.2B $, 2026▲5.4% YoY

Revenue

7.2B $, FY2024▲10.7% YoY

EBITDA

1.1B $, FY2024▼9.1% YoY

Operating margin

14% Industry: -8722▼7.3% YoY

P/E ratio

16.3 Industry: 6▲36.6% YoY

Revenue & EBITDA

$7.2BFY2024 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

1.3B 2024▲23.4% YoY

Capex

209.0M 2024▲61.2% YoY

Debt/equity ratio

0.2 Industry: 2▼NaN% YoY

R&D intensity

8.4%FY2024

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

9.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

7.4

▼ 3.6%

2022

8.0

▼ 4.7%

2023

7.2

▼ 3.0%

2024

9.4

2027

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Available

Human rights policy

Available

Recycling policy

Available

Workplace health & safety policy

Available

29%
Independent Directors

4 out of 14 incl. management

Powered by illuminem

Overall score

92

Environment

99

Social

99

Governance

77

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

image report
Available

Sustainability employees


Total sustainability employees

1


    Available in
    Scale package

    Access
  • Email

  • Email